drugset / Trial / NCT01731730

Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery

NCT01731730 ↗

Phase 2 Completed 102 enrolled Adynxx, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

The objectives of this proof of concept study are to evaluate the safety and preventive analgesic efficacy of a single preoperative intrathecal administration of AYX1 Injection in patients undergoing unilateral total knee arthroplasty.

Timeline

Start
2013-01
Primary completion
2013-10
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Brivoligide Unknown 110 mg Intrathecal
Subject Brivoligide Unknown 330 mg Intrathecal

Indications

No indication recorded.